Nasdaq:US$13.50 (+0.55) | HKEX:HK$22.35 (+0.55) | AIM:£2.26 (+0.09)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2007-06-18

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility